Bactolife
3 known investors
Find your way into Bactolife
Sign up to see every warm intro you have to Bactolife
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bactolife team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bactolife develops Binding Proteins for use in functional foods for humans and in animal feed, aimed at supporting healthy digestion and livestock health. It positions its products as affordable, science-based solutions sold to food producers and the animal feed industry.
Investors · 3
How we know: European Equity Partners's portfolio page · Not right? Tell us
How we know: Novo Holdings's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$34.9M disclosed across 1 of 4 rounds · 2022–2026
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 1
Companies working in the same space as Bactolife.
In the news
Frequently asked questions
- What does Bactolife do?
- Bactolife develops Binding Proteins for use in functional foods for humans and in animal feed, aimed at supporting healthy digestion and livestock health. It positions its products as affordable, science-based solutions sold to food producers and the animal feed industry.
- Who are Bactolife's investors?
- Bactolife's investors include European Equity Partners, Novo Holdings, Cross-Border Impact Ventures.
- How much funding has Bactolife raised?
- Bactolife has disclosed $34.9M raised across 1 of its 4 known rounds.


